Patents Represented by Attorney Mario A. Monaco
  • Patent number: 4402979
    Abstract: This invention relates to ophthalmic preparations which include 5-fluoro-2-methyl-1-(p-methylthiobenzylidene)-3-indenylacetic acid or ophthalmologically acceptable salts thereof as the active entity for reducing or controlling inflammation of the eye.
    Type: Grant
    Filed: October 28, 1981
    Date of Patent: September 6, 1983
    Assignees: Merck & Co., Inc. & Laboratories, Merck, Sharp & Dohme-Chibret
    Inventors: Tsung-Ying Shen, Philippe Conquet, Jean-Claude Le Douarec
  • Patent number: 4401671
    Abstract: Fluorouracil and emimycin are useful in the treatment of giardiasis and trichomoniasis.
    Type: Grant
    Filed: February 10, 1982
    Date of Patent: August 30, 1983
    Assignee: Merck & Co., Inc.
    Inventor: Ching C. Wang
  • Patent number: 4400395
    Abstract: Organic sulfoxides having a latent allyl group bound to the sulfur are enzyme inhibitors of the suicide or K.sub.cat type.
    Type: Grant
    Filed: February 18, 1982
    Date of Patent: August 23, 1983
    Assignee: Merck & Co., Inc.
    Inventor: Raymond A. Firestone
  • Patent number: 4399141
    Abstract: 5-Substituted-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imines, derivatives and pharmaceutically acceptable salts thereof are useful as anticonvulsants.
    Type: Grant
    Filed: June 12, 1981
    Date of Patent: August 16, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Paul Anderson, Marcia E. Christy, Ben E. Evans
  • Patent number: 4399274
    Abstract: Non-ionic, lipophilic substances are isolated from aqueous or aqueous-organic solution by treatment with a macroreticular polymeric absorbent followed by elution with additional or a different organic solvent.
    Type: Grant
    Filed: July 2, 1981
    Date of Patent: August 16, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Robert T. Goegelman, Laszlo R. Treiber
  • Patent number: 4398909
    Abstract: A unit dose applicator for liquid ophthalmic medicaments in solution or suspension has an elongated housing for the medicament; at one end of the housing there is an opening for at least partially emptying the contents of the housing; at the other end of the housing is a second opening; and the second opening is capped by a diaphragm-like seal having a sufficient displacement potential to exude only 1 to 4 drops of the medicament.
    Type: Grant
    Filed: December 31, 1981
    Date of Patent: August 16, 1983
    Inventor: Joel B. Portnoff
  • Patent number: 4394385
    Abstract: The invention relates to the treatment of gray matter edema in the brain or spinal chord by the administration of benzofuranyloxyacetic acids, indeno[5,4-b]furancarboxylic acids, their analogs and salts thereof.
    Type: Grant
    Filed: January 29, 1982
    Date of Patent: July 19, 1983
    Assignee: Merck & Co., Inc.
    Inventor: Edward J. Cragoe, Jr.
  • Patent number: 4393046
    Abstract: Combinations of thiopeptin or one of its analogs with a pyromellitic diimide are shown to synergistically increase the feed efficiency of economically important ruminant animals, especially cattle, sheep, and goats.
    Type: Grant
    Filed: January 30, 1981
    Date of Patent: July 12, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Francis P. Baylis, Gary E. Smith
  • Patent number: 4390546
    Abstract: There is disclosed a macrolide isolated from the fermentation broth of a microorganism identified as MA-5285 which morphological analysis reveals to be a strain of Streptomyces hygroscopicus. The compound's structure is presented based upon analytical studies. The compound has insecticidal and antiparasitic activity.
    Type: Grant
    Filed: December 7, 1981
    Date of Patent: June 28, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Michael A. Goetz, Pamela A. McCormick, Richard L. Monaghan
  • Patent number: 4390537
    Abstract: 1-(Substituted-aminoalkoxyphenyl)-2-methylene-1-alkanones, a class of compounds possessing anti-allergic properties for use in the treatment of allergic conditions, such as asthma prepared by etherifying an alkanoylphenol with an aminoalkyl halide, converting the ether formed to a salt of Mannich base by reacting it with a salt of a secondary amine in the presence of formaldehyde or paraformaldehyde and treating the Mannich salt with a weak base to deaminate the same and form the final product.
    Type: Grant
    Filed: May 19, 1982
    Date of Patent: June 28, 1983
    Assignee: Merck & Co., Inc.
    Inventor: Edward J. Cragoe, Jr.
  • Patent number: 4389397
    Abstract: Ivermectin, an antiparasitic agent which is insoluble and unstable in water, is solubilized by the formation of colloidal particles, called micelles, with surface active agents as solubilizers and stabilized by using cosolvents and/or appropriate substrates in the aqueous formulation. The liquid formulations are suitable for use as parenteral or oral administration for the treatment of parasitic infections.
    Type: Grant
    Filed: September 21, 1981
    Date of Patent: June 21, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Pak-Kan A. Lo, James B. Williams
  • Patent number: 4389417
    Abstract: The invention relates to the treatment of gray matter edema in the brain or spinal chord by the administration of (indanyloxy)acetic acids, and analogs and salts thereof.
    Type: Grant
    Filed: December 30, 1981
    Date of Patent: June 21, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Robert S. Bourke, Edward J. Cragoe, Jr.
  • Patent number: 4388475
    Abstract: Organic sulfoxides having a latent allyl group bound to the sulfur are enzyme inhibitors of the suicide or K.sub.cat type.
    Type: Grant
    Filed: May 7, 1980
    Date of Patent: June 14, 1983
    Assignee: Merck & Co., Inc.
    Inventor: Raymond A. Firestone
  • Patent number: 4388326
    Abstract: Organic sulfoxides having a latent allyl group bound to the sulfur are enzyme inhibitors of the suicide or K.sub.cat type.
    Type: Grant
    Filed: May 7, 1980
    Date of Patent: June 14, 1983
    Assignee: Merck & Co., Inc.
    Inventor: Raymond A. Firestone
  • Patent number: 4386786
    Abstract: A pump is provided with an adjustable tapered seal mechanism so that when wear occurs a simple adjustment is required rather than a dismantling of the pump and replacement with a new seal.
    Type: Grant
    Filed: February 8, 1982
    Date of Patent: June 7, 1983
    Assignee: Merck & Co., Inc.
    Inventor: Ali Agrama
  • Patent number: 4387242
    Abstract: Substances isolated after cultivation of a microorganism belonging to the genus Aspergillus in a culture medium include a compound with structural formula: ##STR1## Together with the corresponding free acid of the above ester, its salts and lactone, compound I is a member of a class of hypocholesterolemic and hypolipemic medicaments.
    Type: Grant
    Filed: August 21, 1981
    Date of Patent: June 7, 1983
    Assignee: Merck & Co., Inc.
    Inventor: Tony Y. K. Lam
  • Patent number: 4386098
    Abstract: 6-Hydroxy-2-benzothiazolesulfonamide is useful for the topical treatment of elevated intraocular pressure. Ophthalmic compositions including drops and inserts are disclosed.
    Type: Grant
    Filed: November 3, 1981
    Date of Patent: May 31, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Otto Woltersdorf, Jr., Stuart R. Michelson, John M. Sondey, Harvey Schwam
  • Patent number: 4386026
    Abstract: Cell-specific ligands comprising conjugates of saccharides and amino acids or peptides are synthesized from amino acids such as ornithine, lysine, peptides such as dilysine, diornithine or oligolysine and selected saccharides having reactive functional groups protected by appropriate blocking groups. Such glycopeptides are useful as tissue specific substances, which when coupled with bioactive materials through metabolizable or hydrolyzable linkages, deliver such bioactive materials to the selected site. In this manner, antiinflammatory drugs such as dexamethasone are linked through a metabolizable or hydrolyzable linkage and on administration to an animal suffering from inflammatory disease carries the drug to the site of inflammation for intracellular release. Other examples include the macrophage ligand N.sup.2 -N.sup.2, N.sup.6 -Bis-[3-(.alpha.-D-mannopyranosylthio)propionyl]-6-lysyl-N.sup.6 -[3-(.alpha.-D-mannopyranosylthio)propionyl]-L-lysine, 5, which when coupled to .beta.
    Type: Grant
    Filed: April 20, 1981
    Date of Patent: May 31, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Mitree M. Ponpipom, Robert L. Bugianesi, James C. Robbins, Tsung-Ying Shen
  • Patent number: 4386103
    Abstract: Dichloroamino acid derivatives other than .alpha.-dichloroamino acids are prepared from chlorination of corresponding amino acids, and are found to be potent germicidal and fungicidal agents.
    Type: Grant
    Filed: January 30, 1981
    Date of Patent: May 31, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Stefano A. Pogany, Takeru Higuchi
  • Patent number: 4385065
    Abstract: There is disclosed a novel series of compounds isolated from the fermentation broth of a strain of the microorganism Streptomyces sp MA5038. The compounds have a 16-membered macrocyclic lactone structure with various substituents thereon. The compounds have insecticidal and antitapeworm activity and compositions for such uses are disclosed.
    Type: Grant
    Filed: October 5, 1981
    Date of Patent: May 24, 1983
    Assignee: Merck & Co., Inc.
    Inventors: George E. Albers-Schonberg, Sebastian Hernandez, Leeyuan Huang